AtaiBeckley (ATAI) Net Income - Minority (2020 - 2021)
AtaiBeckley's (ATAI) quarterly Net Income - Minority came in at -$10.0 million in Q2 2021, down 16.76% quarter-over-quarter from -$8.6 million in Q1 2021.
AtaiBeckley (ATAI) Net Income - Minority (2020 - 2021) Analysis & Trends
AtaiBeckley has disclosed Net Income - Minority across 2 years of filings, most recently posting -$10.0 million for Q2 2021.
- Net Income - Minority for Q2 2021 came in at -$10.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was -$10.0 million (changed N/A YoY), and the FY2020 annual result was -$4.5 million, changed N/A from the prior year.
- Net Income - Minority came in at -$10.0 million for Q2 2021 at AtaiBeckley, down from -$8.6 million in the prior quarter.
- In the past five years, Net Income - Minority ranged from a high of -$4.5 million in Q4 2020 to a low of -$10.0 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -10.05 Mn |
| Mar 31, 2021 | -8.60 Mn |
| Dec 31, 2020 | -4.55 Mn |